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Abstract
The initial distribution volume of glucose (IDVG) can be calculated
from the arterial plasma glucose level between 3 and 7 min after a
bolus intravenous infusion of 5 g glucose. Ishihara and colleagues
have investigated the value of IDVG over the past decade.
Although IDVG is simple and cheap to measure, there have been
several very different proposals regarding what it should be used
for. The most interesting and logical correlate is that between
IDVG and cardiac output. A recent study showed that it does not
matter much whether the calculation of IDVG is based on blood or
plasma samples.
In this issue of Critical Care the Japanese research group
headed by Ishihara [1] highlight the issues involved in
measuring blood glucose. Their approach does not involve
attempting to reduce mortality by controlling the glucose
level; rather, they use its response to a glucose bolus as an
index of physiological parameters such as plasma volume and
cardiac output. Their work is admirable, and more effort
should be given to simplifying the measurement of
parameters that are useful in intensive care. We should not
overlook the potential utility of glucose measurement, as
pioneered by Ishihara over the past decade.
Ishihara and coworkers introduced the concept of the initial
distribution volume of glucose (IDVG), which is determined
by measuring the arterial blood glucose level just before and
repeatedly for about 10 min after a bolus infusion of 5 g
glucose is administered. The data are analyzed by computer
according to a one-compartment kinetic model, in which the
concentration–time profile is represented as a function of
glucose clearance and the volume of distribution of
administered glucose. It is crucial that measurements are
taken from an arterial line because glucose is rapidly
distributed over 65% of the total extracellular fluid volume as
soon as the blood passes through the capillary bed [2].
When measured in this manner the glucose concentration
extrapolated to time zero is diluted in proportion to cardiac
output. This principle is identical to that of thermodilution. The
glucose clearance then becomes a hybrid of the distribution
of exogenous glucose between plasma and the interstitial
fluid and the glucose uptake into cells.
This approach was first reported in 1993, and Ishihara and
coworkers [3,4] concluded that only two samples are needed
to estimate IDVG: one before the bolus infusion and another
3 min later. Such a simplification is justified because
variations in glucose clearance and endogenous glucose
production are of little importance over short time increments,
at least when it is applied in a fairly coherent group of
patients. In subsequent studies, however, sampling was
usually extended to 7 min.
There have been several additional proposals concerning
what IDVG represents. IDVG correlates reasonably well with
plasma volume in bled dogs [5] and with the incidence of
hypovolaemic hypotension after surgery for oesophageal
cancer [6], although these findings may merely reflect the
effect of hypovolaemia on cardiac output. In later studies,
Ishihara and coworkers [7,8] suggested that IDVG is a
measure of the ‘central’ extracellular fluid volume as well as of
cardiac preload.
Their views became more complex when indocyanine green
was introduced as a direct measure of plasma volume. A
deviation in the ratio of indocyanine green to IDVG is said to
indicate capillary leakage of proteins after cardiac surgery,
because this marker binds to proteins [9]. As for glucose
clearance, however, <10 min is a very short period for
ongoing capillary leakage to make a difference. Furthermore,
any such leakage would cancel out if a concentration–time
curve of dye is extrapolated back to time zero. Alternative
explanations should not be overlooked because control
methods designed to measure capillary leak (such as use of
radioactive albumin) were not applied, and a similar increase
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in the indocyanine/IDVG ratio also occurs early after
induction of intravenous anaesthesia [10] and after
administration of histamine [11].
All of these ideas about the physiological meaning of IDVG
may be difficult to differentiate for the intensivist. Although
IDVG perhaps most directly reflects a fraction of the
extracellular fluid volume, several of Ishihara and coworkers’
later studies actually strongly support their first interpretation,
namely that IDVG indicates cardiac output. This correlation
between IDVG and cardiac output is logical and renders
IDVG highly useful because it both predicts a key parameter
in body physiology and can be measured quickly and with
little effort and cost. Unfortunately, this view is somewhat
countered by the fact that IDVG is said to be undisturbed by
vasoactive drugs, although most of these agents actually
change cardiac output [12].
What the limits are and the errors that may be hidden in the
determination of IDVG are the most recent issues. IDVG is
apparently accurate if it is repeated after 30 min in clinical
patients [13], although the study presented in this issue [1]
holds that blood glucose remains elevated for another
30 min, which is also the case in healthy individuals (Fig. 1).
In study presented in this issue, Ishihara and coworkers [1], in
addition to repeating their previous finding that a 3-min
postinfusion sample is sufficient to predict IDVG [3,4], also
compare calculations of IDVG based on plasma glucose and
blood glucose. The difference is quite small and, logically,
should be accounted for by displacement of glucose from the
parts of the red blood cells that consist of haemoglobin. The
authors found no correlation between the plasma–blood
difference in IDVG and the haematocrit, but I believe that
haemoglobin would be a more reasonable comparitor
because haemoglobin reflects differences in the water
content of blood [14]. Nevertheless, the authors conclude
that measurements can be based on both plasma and blood
samples, although these are not interchangeable. Once
chosen, use of either body fluid should probably be
consistent.
It appears that the IDVG will be ready for limited
implementation once it has been tested by additional
independent groups. The method is safe and easy to apply,
but intensivists must reach a consensus about its place in the
clinic and what it really shows. I foresee that IDVG may serve
as a screening test to separate patients with a hyperkinetic
circulation from those with a hypokinetic one.
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